Isolated Plasmacytoma of Bone: Clinical Trials

3 trials for Isolated Plasmacytoma of Bone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Isolated Plasmacytoma of Bone: new trials by email Literature Review of Isolated Plasmacytoma of Bone trials Research Report on Isolated Plasmacytoma of Bone

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
tetanus-CMV fusion peptide vaccine, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1CompletedCity of Hope Medical Center362012-10-292024-04-02
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
sunitinib malate, pharmacological study, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Phase 1CompletedNational Cancer Institute (NCI)422009-08-012014-03-17
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
imatinib mesylate, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Phase 1CompletedNational Cancer Institute (NCI)602001-08-012013-02-07

Narrower conditions

Burkitt Lymphoma (3)  ·  Hodgkin Disease (3)  ·  Leukemia, Hairy Cell (3)  ·  Leukemia, Large Granular Lymphocytic (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Myeloid, Accelerated Phase (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Leukemia, Myeloid, Chronic-Phase (3)  ·  Leukemia, Myelomonocytic, Chronic (3)  ·  Leukemia, Prolymphocytic (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Lymphoma, Large-Cell, Anaplastic (3)  ·  Lymphoma, Mantle-Cell (3)

Broader conditions

Blood Coagulation Disorders (3)  ·  Blood Platelet Disorders (3)  ·  Blood Protein Disorders (3)  ·  Bone Marrow Diseases (3)  ·  Bone Marrow Neoplasms (3)  ·  Cardiovascular Diseases (3)  ·  Chronic Disease (3)  ·  DNA Virus Infections (3)  ·  Disease Attributes (3)  ·  Epstein-Barr Virus Infections (3)  ·  Hematologic Diseases (3)  ·  Hematologic Neoplasms (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)

Interventions

Imatinib Mesylate (1)  ·  Sunitinib (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  City of Hope Medical Center (1)

Countries

United States (3)

Top investigators

John Deeken (1)  ·  Ramesh Ramanathan (1)  ·  Ryotaro Nakamura (1)

Results publications

PMID 22259028, PMID 24474568, PMID 26853648, PMID 30562587

NIH funding

U01CA062487 (1), U01CA062491 (1), U01CA062502 (1), U01CA062505 (1), U01CA099168 (1), U01CA121947 (1)